Case Report: Malignant peritoneal mesothelioma with TFG-ROS1 fusion responds to crizotinib
<i>ROS1</i> rearrangement could potentially represent a novel driver mutation in MPM, especially in female adults. This case report illustrates the benefits of molecular detection in MPM and underscores the potential for lessons learned from other solid tumors to inform treatment strategies for rare diseases.
Authors
- Cong Fu (ORCID: https://orcid.org/0000-0002-4306-0594)
- Peng Li (ORCID: https://orcid.org/0000-0002-9153-2955)
- Wei Ye (ORCID: https://orcid.org/0000-0002-3804-2447)
Institutions
- Hangzhou Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-16
- DOI
- https://doi.org/10.3389/fonc.2025.1617457
- Primary Topic
- Occupational and environmental lung diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00